Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 515-520

  Smolders, Joost ^a,b   Damoiseaux, Jan ^b   Menheere, Paul ^a   Tervaert, Jan Willem Cohen ^a   Hupperts, Raymond ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Division of Clinical and Experimental Immunology   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

Author keywords

1,25 dihydroxyvitamin D; 25 hydroxyvitamin D; Genetic polymorphism; Multiple sclerosis; Vitamin D; Vitamin D receptor

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; ALLELE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; MORBIDITY; MULTIPLE SCLEROSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SUMMER; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM; WINTER;

EID: 67349108483     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04656.x     Document Type: Conference Paper

References (20)

1. Smolders, J. et al. 2008. Vitamin D as an immune modulator in multiple sclerosis, a review. J. Neuroim-munol. 194: 7-17.
2. Arnson, Y., H. Amital & Y. Shoenfeld. 2007. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann. Rheum. Dis. 66: 1137-1142.
3. Cantorna, M.T. 2008. Vitamin D and multiple sclerosis: an update. Nutr. Rev. 66: s135-s138.
4. Adorini, L. & G. Penna. 2008. Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 4: 404-412.
5. Hollis, B.W. 1996. Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif. Tissue Int. 58: 4-5.
6. Munger, K.L. et al. 2006. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296: 2832-2838.
7. Smolders J. et al. 2008. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult. Scler. 14: 1220-1224.
8. Uitterlinden, A.G. et al. 2004. Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states. J. Steroid Biochem. Mol. Biol. 89-90: 187-193.
9. Yeo, T.W. et al. 2004. Four single nucleotide polymorphisms from the vitamin D receptor gene in UK multiple sclerosis. J. Neurol. 251: 753-754.
10. Steckley, J.L. et al. 2000. Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology 54: 729-732.
11. Niino, M. et al. 2000. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J. Neurol. Sci. 177: 65-71.
12. Orton, S.M. et al. 2008. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am. J. Clin. Nutr. 88: 441-447.
13. Fukazawa, T. et al. 1999. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J. Neurol. Sci. 166: 47-52. (Pubitemid 29327245)
14. Partridge, J.M. et al. 2004. Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology 62: 2323-2325.
15. Tajouri, L. et al. 2005. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J. Neurogenet. 19: 25-38.
16. Smolders, J. et al. 2009. Fokl vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. J. Neuroimmunol. 207: 117-121.
17. McDonald, W.I. et al. 2001. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50: 121-127.
18. Colin, E.M. et al. 2000. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin. Endocrinol. (Oxf.) 52: 211-216.
19. van Etten, E. et al. 2007. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur. J. Immunol. 37: 395-405.
20. Marshall, T.G. 2008. Vitamin D discovery outpaces FDA decision making. Bioessays 30: 173-182.